Skip to main content

Table 5 Cox-regression analysis of predictors of mortality of TB/HIV co-infected children attending ART clinics of public hospitals in SNNPR, Ethiopia from January 2009 to December 2019

From: Predictors of mortality among TB-HIV co-infected children attending anti-retroviral therapy clinics of selected public hospitals in southern, Ethiopia: retrospective cohort study

Variables

Categories

Death

Censored

CHR

AHR

Time of TB diagnosis

Pre ART

18

153

0.52 (0.26-1.03)

0.5 (0.18-1.36)

ART

17

96

1

1

WHO stage at TB diagnosis

III

14

169

1

1

IV

21

80

3.0 (1.53-5.95)

1.61 (0.71-3.67)

Hemoglobin level

≤10 mg/dl

27

89

5.23 (2.37-11.54)

3.6 (1.39-9.31)*

> 10 mg/dl

8

160

1

1

Site of TB

Pulmonary

25

232

1

1

Extrapulmonary

10

17

4.2 (2.02-8.81)

3.9 (1.34-11.45)*

TB drug resistance

No

27

237

1

1

MDR

8

12

5.1 (2.31-11.31)

5.7 (2.07-15.96)*

ART drug adherence

Good

28

238

1

1

Fair/Poor

7

11

4.02 (1.75-9.22)

2.9 (1.15-7.43)*

Previous history of TB

Yes

14

53

4.1 (2-8.33)

2.63 (1.07-6.44)

No

21

196

1

1

ART treatment failure

Yes

3

37

0.46 (0.14-1.5)

0.56 (0.16-1.93)

No

212

32

1

1

IPT

Yes

19

163

1

1

No

16

86

1.65 (0.85-3.22)

0.55 (0.26-1.15)

Baseline PTB

Yes

20

159

0.55 (0.27-1.14)

2.3 (0.66-8.17)

No

15

90

1

1

Baseline EPTB

Yes

4

13

2.3 (0.8-6.5)

0.97 (0.24-3.9)

No

31

236

1

1

Baseline oral thrush

Yes

3

11

2.44 (0.74-8.01)

3.7 (1.02-13.39)

No

32

238

1

1

Baseline esophageal thrush

Yes

2

6

3.3 (0.79-13.93)

4.4 (0.77-25.02)

No

33

243

1

1

  1. CHR crude hazard ratio, AHR adjusted hazard ratio, *significantly associated variables with P < 0.05.